Filing Details
- Accession Number:
- 0001415889-24-028289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 17:20:14
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 17:20:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578850 | Gregory Neil Almstead | C/O Ptc Therapeutics, Inc. 500 Warren Corporate Center Drive Warren NJ 07059 | Chief Technical Ops Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 2,594 | $51.00 | 88,796 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 2,328 | $51.85 | 86,468 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 266 | $52.73 | 86,202 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 66,956 | $51.00 | 153,158 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 58,345 | $51.97 | 94,813 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 8,611 | $52.72 | 86,202 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 2,060 | $51.00 | 6,636 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2024-12-02 | 1,783 | $51.85 | 4,853 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2024-12-02 | 277 | $52.76 | 4,576 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 2,594 | $0.00 | 2,594 | $51.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 66,956 | $0.00 | 66,956 | $51.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 2,060 | $0.00 | 2,060 | $51.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 66,956 | 2025-01-02 | No | 4 | M | Direct | |
| 0 | 2025-01-02 | No | 4 | M | Direct | |
| 0 | 2025-01-02 | No | 4 | M | Indirect |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.47 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.58 to $52.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.505 to $52.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on February 21, 2023.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.65 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Currently exercisable.
Billionaire Hedge Funds
